Corrigendum to “The Long-Term Safety and Efficacy of Vestronidase Alfa, Rhgus Enzyme Replacement Therapy, in Subjects with Mucopolysaccharidosis Vii” [Mol Genet Metab 2020 Mar;129(3):219–227] (Molecular Genetics and Metabolism (2020) 129(3) (219–227), (S1096719219307851), (10.1016/J.ymgme.2020.01.003))

AuthID
P-00S-N2X
11
Author(s)
Wang, RY
·
da Silva Franco, JF
·
López Valdez, J
·
Sutton, VR
·
Whitley, CB
·
Zhang, L
·
Cimms, T
·
Marsden, D
·
Jurecka, A
·
Harmatz, P
Document Type
Correction
Year published
2020
Published
in Molecular Genetics and Metabolism, ISSN: 1096-7192
Indexing
Publication Identifiers
Scopus: 2-s2.0-85089738882
Source Identifiers
ISSN: 1096-7192
Export Publication Metadata
Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.